Content is available to registered users only. Registration is free.
Register now, or if you’ve already registered, log in.
Jason Wermers, CRTonline.org
The Symplicity Spyral Renal Denervation System received marketing approval from the U.S. Food and Drug Administration (FDA) to treat hypertension, Medtronic announced Friday.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details